Literature DB >> 30763585

Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.

Wang Zhang1, Yuntao Zhang2, Yuxian He3, Xiying Wang3, Qiang Fang4.   

Abstract

Macrophages are dynamic cells whose phenotypes and functions are regulated by surrounding inflammatory mediators after pathogenic infection. Imbalanced polarization of classically activated (M1) and alternatively activated (M2) macrophages is closely associated with infection-related complications and their severity. The pathway of T-cell immunoglobulin mucin 3 (Tim-3)/galectin-9 (Gal-9) plays an important role in infection by regulating macrophage function. However, the effects of Tim-3/Gal-9 signalling on M1/M2 macrophage polarization are unclear. Bone marrow-derived macrophages (BMDMs) were stimulated with 0.1 μg/mL lipopolysaccharide (LPS). M1/M2 phenotypic macrophage markers were measured 0, 1, 3, 6, 12, and 24 h after stimulation, α-lactose was used to inhibit Gal-9, anti-mouse Tim-3 antibody was used to block Tim-3, recombinant mouse-Gal-9 (rm-Gal-9) was used to activate Tim-3, which were aimed to verify the role of the Tim-3/Gal-9 pathway in the balance of M1/M2 macrophages when stimulated with LPS. Short-term LPS stimulation upregulated Gal-9 expression and secretion, enhanced the association between Gal-9 and Tim-3, and activated the Tim-3/Gal-9 signalling pathway, eventually inhibiting M1 polarization. Long-term stimulation downregulated Gal-9 expression and secretion, reduced the association between Gal-9 and Tim-3, and inhibited the Tim-3/Gal-9 signalling pathway, eventually promoting M1 polarization, however, decreased M2 polarization and Gal-9 autocrine functions. Overall, LPS had a biphasic effect on BMDMs polarization through the Tim-3/Gal-9 pathway, which was time-dependent.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Galectin-9; Lipopolysaccharide; Macrophages; Polarization; Tim-3

Mesh:

Substances:

Year:  2019        PMID: 30763585     DOI: 10.1016/j.yexcr.2019.02.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  18 in total

Review 1.  Regulation of wound healing and fibrosis by galectins.

Authors:  Dong Yu; Ming Bu; Ping Yu; Yaping Li; Yang Chong
Journal:  J Mol Med (Berl)       Date:  2022-05-19       Impact factor: 4.599

2.  Clinical value of the sTim‑3 level in chronic kidney disease.

Authors:  Lingli Chen; Yuan Qin; Bo Lin; Xiaomei Yu; Shaoxiong Zheng; Xiumei Zhou; Xiaobin Liu; Yigang Wang; Biao Huang; Juan Jin; Liang Wang
Journal:  Exp Ther Med       Date:  2022-07-29       Impact factor: 2.751

3.  Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma.

Authors:  Xiangrong Ni; Weichi Wu; Xiaoqiang Sun; Junxiao Ma; Zhihui Yu; Xinwei He; Jinyu Cheng; Pengfei Xu; Haoxian Liu; Tengze Shang; Shaoyan Xi; Jing Wang; Ji Zhang; Zhongping Chen
Journal:  Sci Adv       Date:  2022-07-08       Impact factor: 14.957

4.  Activation of Macrophages by Lysophosphatidic Acid through the Lysophosphatidic Acid Receptor 1 as a Novel Mechanism in Multiple Sclerosis Pathogenesis.

Authors:  Guillermo Estivill-Torrús; Beatriz García-Díaz; Jennifer Fransson; Ana Isabel Gómez-Conde; Jesús Romero-Imbroda; Oscar Fernández; Laura Leyva; Fernando Rodríguez de Fonseca; Jerold Chun; Celine Louapre; Anne Baron Van-Evercooren; Violetta Zujovic
Journal:  Mol Neurobiol       Date:  2020-09-24       Impact factor: 5.590

Review 5.  MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism.

Authors:  Valerie Planat-Benard; Audrey Varin; Louis Casteilla
Journal:  Front Immunol       Date:  2021-04-30       Impact factor: 7.561

6.  The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy.

Authors:  Sashi Kandel; Pratik Adhikary; Guangfu Li; Kun Cheng
Journal:  Cancer Lett       Date:  2021-04-22       Impact factor: 9.756

Review 7.  Targeting cell signaling in allergic asthma.

Authors:  Seyyed Shamsadin Athari
Journal:  Signal Transduct Target Ther       Date:  2019-10-18

8.  Exosomes released by breast cancer cells under mild hyperthermic stress possess immunogenic potential and modulate polarization in vitro in macrophages.

Authors:  Kacoli Sen; Austin E F Sheppe; Ishita Singh; Winnie W Hui; Mariola J Edelmann; Carlos Rinaldi
Journal:  Int J Hyperthermia       Date:  2020       Impact factor: 3.914

9.  Tim‑3 regulates the ability of macrophages to counter lipopolysaccharide‑induced pulmonary epithelial barrier dysfunction via the PI3K/Akt pathway in epithelial cells.

Authors:  Yuntao Zhang; Wang Zhang
Journal:  Mol Med Rep       Date:  2020-05-04       Impact factor: 2.952

Review 10.  Different Macrophage Type Triggering as Target of the Action of Biologically Active Substances from Marine Invertebrates.

Authors:  Lyudmila S Dolmatova; Igor Yu Dolmatov
Journal:  Mar Drugs       Date:  2020-01-02       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.